These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 8706727)

  • 1. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
    Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
    Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
    Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
    Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5).
    de Meester I; Vanhoof G; Lambeir AM; Scharpé S
    J Immunol Methods; 1996 Jan; 189(1):99-105. PubMed ID: 8576585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
    Ruiz P; Zacharievich N; Shenkin M
    Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure and function of CD26 in the T-cell immune response.
    Morimoto C; Schlossman SF
    Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
    Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
    Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
    Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
    Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
    Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
    Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
    Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
    Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
    Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M
    J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).
    Kahne T; Lendeckel U; Wrenger S; Neubert K; Ansorge S; Reinhold D
    Int J Mol Med; 1999 Jul; 4(1):3-15. PubMed ID: 10373631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
    Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
    J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J; Olek S; Fleischer B; von Bonin A
    Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26).
    Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
    J Biol Chem; 1995 Jun; 270(23):14107-14. PubMed ID: 7539799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.